Year : 2018  |  Volume : 12  |  Issue : 1  |  Page : 69-75

Serum interleukin 23 and its associations with interstitial lung disease and clinical manifestations of scleroderma

1 Department of Rheumatology, Rehabilitation and Physical Medicine, Faculty of Medicine, Benha University, Benha, Egypt
2 Chest Diseases Department, Faculty of Medicine, Benha University, Benha, Egypt

Correspondence Address:
Tahany M.A Gouda
Chest Diseases Department, Faculty of Medicine, Benha University, Benha
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/ejb.ejb_22_17

Rights and Permissions

Introduction Systemic sclerosis (SSc) is a complex disease linked to immune system activation, vascular damage, associated with increased synthesis, and deposition of extracellular matrix, which contain excessive amounts of structurally normal collagen. Interleukin 23 (IL-23) might play a role in disease development and severity. This study aimed to assess the relationship between serum level of IL-23 and interstitial lung disease in SSc. Patients and methods Thirty patients with SSc together with 30 age-matched and sex-matched healthy volunteers were recruited in this study. Serum IL-23 levels were measured by enzyme-linked immunosorbent assay. Functionally, lung involvement was assessed by pulmonary function tests and radiologically by chest radiography and high-resolution computed tomography of the lungs. Results Mean serum IL-23 level was significantly highly elevated in SSc patients compared with healthy controls (P<0.005). Patients with elevated IL-23 levels exhibited shorter disease duration (P<0.05). Moreover, mean serum IL-23 level was elevated in diffuse SSc cases compared with limited SSc cases and in cases with pulmonary fibrosis (P<0.05), although they were not associated with other clinical features. Elevated mean serum IL-23 level was significantly higher in mild restrictive cases compared with moderate and severe restrictive cases. As regards high-resolution computed tomography, mean serum IL-23 level was statistically highly significantly elevated in cases with ground-glass appearance (P<0.001) compared with others. Conclusion Alterations in serum concentrations of IL-23 support the hypothesis that IL-23 is associated with induction of SSc generally and SSc associated with interstitial lung disease specifically. Presumably, blockage of IL-23 could be used as a potential therapeutic target in early SSc.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded28    
    Comments [Add]    

Recommend this journal